A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

• Status: RECRUITING
• Trial end date: 2026-06-30

Summary

This is a Phase 1 study to assess the safety of ERX-315 in patients with advanced solid tumors that have failed approved systemic therapies.

• Phase: PHASE1

Details

• Lead Sponsor: EtiraRx Australia Pty Ltd